Uppsala Monitoring Centre

Are you a physician or pharmacist with recent experience in healthcare or research looking to join a multidisciplinary team? Our Signal Management section is #hiring a Pharmacovigilance Scientist to work with the detection of safety signals. This investigative work involves the clinical assessment of case series, dissemination of findings, and close collaboration with other teams at UMC and WHO, among other tasks. Applications will be reviewed on a rolling basis, with a final deadline of 13 August 👉 ow.ly/PlGr50SFaLi 🎥 Watch our video 'The WHO PIDM in Focus - Signal detection' to learn more about the daily work of our Signal Management team 👉 ow.ly/ej8i50SFaLj

💉🌍 Vaccine safety monitoring, surveillance activities, and #PublicHealth communications continue to grow in Africa.    Earlier this month, representatives from East and Southern African countries met in Johannesburg, South Africa, for a training session. UMC's Peter Hjelmstrom, Malin Jakobsson, and Sara Oliveira were pleased to attend and discuss using #VigiMobile to collect and manage safety data (ADRs and AEFIs). We were thrilled to meet colleagues during this 3-day meeting from immunisation and regulatory authorities, the World Health Organization, WHO AFRO, the African Vaccine Regulatory Forum (AVAREF), the Centers for Disease Control and Prevention, and Africa CDC, among other partners.     We look forward to following the continued progress towards strengthening #pharmacovigilance systems in the region and beyond ✅     📷 WHO

🎧 Catch up on recent #DrugSafetyMatters episodes and stay informed about some of the most pressing issues in the world of medicines safety. Our latest episodes explore: 🤖 Trust in AI/ML with Michael Glaser ❓ Medication errors with Loubna Alj, Ghita Benabdallah, and Alem Zekarias 🧠 Behavioural side effects with Michele Fusaroli Tune in 👉 drugsafetymatterspod.org #AI #ML #MedicationErrors #pharmacovigilance

What factors influence the quality of adverse event reports submitted to #VigiBase? The completeness of adverse event reports is measured using the vigiGrade completeness score in VigiBase, the World Health Organization global database of adverse event reports for medicines and vaccines. In JMIR Publications Medical Informatics, UMC's Daniele Sartori and colleagues in Malaysia and Taiwan utilise machine learning and time-series analyses to determine the driving factors behind Malaysia's high vigiGrade completeness score. Open access article 🌐 doi.org/10.2196/49643 #MachineLearning #pharmacovigilance

Have you registered? UMC is pleased to participate in this year's ISPE Annual Meeting in Berlin, Germany. Join us and the International Society for Pharmacoepidemiology as they celebrate 40 years of advancing #pharmcoepidemiology: #ISPEAnnual2024  📆 24–28 August  📍 Estrel Congress Centre, Berlin 🇩🇪 More information and registration in the post below👇

#Misinformation is still rife on the internet, with numerous websites providing unbalanced, misleading, and alarming information about #VaccineSafety. Finding reliable sources of trusted vaccine information that adhere to good information practices can be challenging for users.     The Vaccine Safety Net project (VSN), a diverse global network of websites promoting credible and science-based information, aims to change that.      For #UppsalaReports, Shanthi Pal and Xinyu Weng tell us more about the VSN and the work of the World Health Organization to ensure scientifically accurate vaccine safety information reaches people from all walks of life👇

📣 Preparations for #MedSafetyWeek 2024 continue! This year's campaign takes place from 4 to 10 November on preventing side effects.       We recently met with Spanish-speaking participants to discuss campaign essentials, tips and tricks for crafting creative materials, and how to engage partners to amplify messages.    Thanks to everyone who joined us, especially Cesar Luis Avalos Capristan (Ministerio de Salud del Perú) for his inspiring presentation!   Learn more about our annual campaign at 🌐 who-umc.org/medsafetyweek

The use of natural products and herbal medicines is engrained in many cultures. Yet awareness of their safe use, or #phytovigilance, is severely lacking in #healthcare.    Mohamed A. Elhawary and Hadir Rostom outline how the ISoP Egypt Chapter created an outreach proposal centred on sharing information, experiences, and anecdotes of the safety of herbals.   Get the full story in #UppsalaReports👇

Artificial intelligence and machine learning are technologies that continue to rapidly develop in complexity and deployment. How can we balance their adoption, data protection, and patient safety when it comes to #pharmacovigilance?     Michael Glaser (GSK) joins us in the latest #UppsalaReports Long Reads to discuss his article and how to ensure trust in #AI and #ML.    Listen in on #DrugSafetyMatters 🎧 ow.ly/V0t450SuutL

⏱️ Do you have 3 minutes to spare? Help us improve our website 🌐 We are seeking valuable input from YOU, our users, to help us inform the refresh of our public website (who-umc.org). Please complete our short survey to tell us what you think – thank you! Access the survey via this link 👉 ow.ly/YR2q50SiJ2z